[{"Assets_0_Q1_USD":4722841000.0,"CommonStockSharesConverted_0_Q1_shares":180761969.0,"CommonStockSharesOutstanding_0_Q1_shares":180761969.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-15194000.0,"NetIncomeLossConverted_1_Q1_USD":81381000.0,"StockholdersEquity_0_Q1_USD":3239962000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":187163000.0,"EarningsPerShareBasic_1_Q1_USD":0.45,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":179898000.0,"EarningsPerShareDiluted_1_Q1_USD":0.44,"RevenuesConverted_1_Q1_USD":502069000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20200331","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200501"}]